ARP Rheumatology
ARP Rheumatology


ARP Rheumatology
Original article

Sex differences in axial spondyloarthritis: data from a Portuguese spondyloarthritis cohort


Cunha R, Vieira-Sousa E, Khmelinskii N, Ávila-Ribeiro P, Couto M, Seixas M, Martins N, Bernardes M, Martins A, Silva Ad, Lourenço M, Miguel C, Tavares V, Valente P, Costa J, Rovisco J, Aguiar R, Afreixo V, Barcelos A


Background: Axial spondyloarthritis (axSpA), particularly ankylosing spondylitis was historically considered a male’s disease and has been under-recognized in women. Emerging evidence reveals sex differences in pathophysiology, disease presentation and therapeutic efficacy. Objective: To identify differences between sexes in a Portuguese cohort of patients with axSpA regarding clinical manifestations, disease activity, functional capacity, patient related outcomes and presence of sacroiliitis on x-ray or magnetic resonance imaging. Methods: Patients with ≥18 years fulfilling the ASAS- Assessment of Spondyloarthritis International Society classification criteria for axSpA registered in the electronic Rheumatic Diseases Portuguese Register ( were included in this multicentric cross-sectional study. Sociodemographic data, clinical features and imaging were collected from the first record in These variables were compared between sexes using Mann-Whitney test and Chi-Square test. Variables with a significant association with variable sex were considered in the multiple variable analysis to adjust the sex effect on the outcome variables. Statistical analysis was performed with R version 4.0.2 and p <0.05 was considered statistically significant. Results: A total of 1995 patients were included, 1114 (55.9%) men and 881 (44.1%) women. Men had an earlier disease onset (25.1 vs 28.4, p <0.001), were younger at diagnosis (26.9 vs 30.4, p<0.001) and were more frequently smokers (32.1% vs 15.7%, p <0.001). Comparing to women, men had worse Bath Ankylosing Spondylitis Metrological Index scores (4.0 vs 3.4, p<0.001), higher levels of C-Reactive Protein (10.5 vs 6.9 mg/L, p <0.001) and were more often Human Leukocyte Antigen-B27 positive (67.8% vs 54%, p <0.001). In contrast, women more frequently had inflammatory bowel disease (8.8% vs 4.9%, p =0.004), higher levels of erythrocyte sedimentation rate (25.0 vs 21.0mm/h, p=0.003) and worse patient-related outcomes- Bath Ankylosing Spondylitis Disease Activity Index (5.7 vs 4.5, p<0.001), Patient Global Assessment (60.0 vs 50.0, p <0.001) and fatigue (6.2 vs 5.0, p <0.001). Discussion: In this large multicentric study from a Portuguese axSpA cohort, we confirmed sex differences in patients with axSpA. This work brings awareness to these differences, resulting in less underdiagnosis and misdiagnosis, optimizing treatment strategies, and improving outcomes in axSpA.







Rita Cunha, Elsa Vieira-Sousa, Nikita Khmelinskii, Pedro Ávila-Ribeiro, Maura Couto, Maria Seixas, Nádia Martins, Miguel Bernardes, Ana Martins, Ana da Silva, Maria Lourenço, Cláudia Miguel, Viviana Tavares, Paula Valente, José Costa, João Rovisco, Renata Aguiar, Vera Afreixo, Anabela Barcelos. Sex differences in axial spondyloarthritis: data from a Portuguese spondyloarthritis cohort. ARP Rheumatology, Vol 1, nº1 2022:42-48. PMID: 35633576
Copy citation

This browser does not support PDFs. Please download the PDF to view it: Download PDF.